Empagliflozin/linagliptin - Boehringer Ingelheim
At a glance
- Drug Originator Boehringer Ingelheim
- Drug Licenced by Cipla; Eli Lilly and Company; Lupin
- Drug Class Alkynes; Antihyperglycaemics; Piperidines; Purines; Quinazolines; Small molecules
- Mechanism of Action Dipeptidyl peptidase 4 inhibitors; Sodium-glucose transporter 2 inhibitors
- USA Patent Applicants BOEHRINGER INGELHEIM
- USA Patents 38
- NDAs 1
- International Patents 605
Table of Contents
Disclaimer